GenSpera, Inc.: Clinical Trials

5 completed, 2 withdrawn, 1 no longer available. 6 Phase 2, 1 Phase 1.

By phase and status

Phase	Trials	Status
Phase 2	6	Completed 4, Withdrawn 2
Phase 1	1	Completed 1

Follow GenSpera, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Efficacy and Safety of G-202 in PSMA-Positive Glioblastoma G-202 - Glioblastoma	Phase 2	Withdrawn	GenSpera, Inc.		2016-09-01	2017-02-24
Safety and Activity of G-202 in Patients With Clear Cell Renal Cell Carcinoma That Expresses PSMA G-202 - Clear Cell Renal Cell Carcinoma	Phase 2	Completed	GenSpera, Inc.	2	2016-06-01	2017-02-24
G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancer G-202 - Prostatic Neoplasms	Phase 2	Completed	GenSpera, Inc.	1	2016-02-01	2017-02-24
Efficacy, Safety and CNS Exposure of G-202 (Mipsagargin) in Patients With Recurrent or Progressive Glioblastoma G-202 - Glioblastoma Multiforme	Phase 2	Completed	GenSpera, Inc.	26	2014-02-01	2024-05-21
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer G-202 - Prostate Cancer.	Phase 2	Withdrawn	GenSpera, Inc.		2013-05-01	2014-02-19
Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma G-202 - Advanced Adult Hepatocellular Carcinoma	Phase 2	Completed	GenSpera, Inc.	25	2013-01-01	2016-08-23
Dose-Escalation Phase 1 Study of G-202 (Mipsagargin) in Patients With Advanced Solid Tumors G-202 - Advanced Solid Tumors	Phase 1	Completed	GenSpera, Inc.	30	2010-01-01	2015-12-10
Continued Administration of G-202 for One Patient With Advanced Hepatocellular Carcinoma G-202 - Hepatocellular Carcinoma		No longer available	Devalingam Mahalingam			2014-03-10

Conditions studied

Carcinoma, Hepatocellular (2)  ·  Glioblastoma (2)  ·  Prostatic Neoplasms (2)  ·  Carcinoma, Renal Cell (1)  ·  Liver Neoplasms (1)

Countries

United States (7)

Top investigators

Devalingam Mahalingam, MD (2)  ·  Robert Amato, D.O. (2)  ·  David Piccioni, M.D., Ph.D. (1)  ·  Devalingam Mahalingam, M.D., Ph.D. (1)  ·  Garni Barkhoudarian, M.D. (1)  ·  George Wilding, M.D (1)  ·  Michael Carducci, M.D. (1)